期刊文献+

不同剂量丙种球蛋白治疗川崎病临床疗效比较

The comparison of clinical effect of gamma globulin with different doses and method of application in the treatment of Kawasaki disease
原文传递
导出
摘要 目的比较不同剂量丙种球蛋白治疗川崎病的临床疗效,探讨丙种球蛋白治疗川崎病的最优方案。方法将纳入标准的川崎病患儿随机分为3组,观察对比3组患儿临床结局、症状消退时间、实验室指标恢复情况及相关并发症的发生情况。结果①B组(每日1g/kg组)及C组(每日2g/kg组)治愈率均高于A组(每日400mg/kg组)。②B组及C组症状消退时间均短于A组。③C组患儿实验室指标治疗后均低于治疗前。④B组及C组患儿治疗期间心血管并发症低于A组。结论静脉滴注丙种球蛋白每日2g/kg治疗1d与每日1g/kg连用2d两种方案治疗川崎病能更快速控制各临床症状、改善各项指标,有助于恢复,且治愈率高。 Objective To compare the clinical effect of different dose of Gammaglobulin in the treatment of Kawasaki Disease(KD),and explore the best scheme of treatment of KD with Gammaglobulin.Methods Children with Kawasaki Disease were randomly divided into 3 groups to observe and compare the clinical outcome symptom disappearance time,the recovery of laboratory indexes and the occurrence of related complications.Results ①The cure rate of B groups(1 g/kg daily) and C groups(2 g/kg daily) was higher than that of A Group(400 mg/kg daily).②The time of symptom subsiding in group B and C was shorter than that in Group A.③The laboratory indexes of C groups were lower after treatment than before treatment.④The cardiovascular complications in Group B and C were lower than that in Group A.Conclusion The two regimens of intravenous Immunoglobulin(Ivig) 2 g/kg per day for 1 day and 1 g/kg per day for 2 days can both control the clinical symptoms and improve the indexes of Kawasaki Disease more quickly,which remarkely shorten the recovery time and have a high cure rate.
作者 胡家华 张永峰 HU Jialiua;ZHANG Yongfeng(Department of Pediatrics,the Affiliated Hospital of Weifang Medical University,Weifang 261031,China)
出处 《潍坊医学院学报》 2020年第3期164-166,共3页 Acta Academiae Medicinae Weifang
关键词 川崎病 丙种球蛋白 不同剂量 临床疗效 Kawasaki disease Gamma globulin Different dosage Clinical effect
  • 相关文献

参考文献10

二级参考文献93

  • 1Nakamura Y, Rashiro M, Uehara R, et al. Epidemiologic features ofKawasaki disease in Japan: results of the 2009-2010 Nationwide sur-vey [J]. J Epidemiol,2012, 22 (3} : 216-221. 被引量:1
  • 2Newburger JW, Tskahashi M, Gerber MA, et al. Diagnosis, treat-ment, and long-term management of Kawasaki disease: a statementfor health professionals from4he Committee on Rheumatic Fever,Endocarditis, and Kawasaki Disease, Council on CardiovascularDisease in the Young, American Heart Association [J].Pediatrics,2004, 114(6): 1708-1733. 被引量:1
  • 3g KP, Hsieh KS, Ho TY, etal. IL-1B polymorphism in associationwith initial intravenous immunoglobulin treatment failure in Taiwanesechildren with Kawasaki disease [J]. Circ J, 2010, 74(3): 544-551. 被引量:1
  • 4Lau AC, Duong TT, Ito S, et al. Intravenous immunoglobulin andsalicylate differentially modulate pathogenic processes leadingto vascular damage in a model of Kawasaki disease [J]. ArthritisRheum, 2009, 60(7): 2131-2141. 被引量:1
  • 5Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plusprednisolone for prevention of coronary artery abnormalities in severeKawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial [J]. Lancet, 2012, 379(9826): 1613-1620. 被引量:1
  • 6Takatsuki S, Ito Y, Taheuchi D, et al. IVIG reduced vascular oxi-dative stress in patients with Kawasaki disease [J]. Circ J, 2009,73(7): 1315-1318. 被引量:1
  • 7Fong NC, Hui YW, Li CK, et al. Evaluation of the efficacy of treat-ment of Kawasaki disease before day 5 of illness [J]. Pediatr Car-diol, 2004,25(1): 31-34. 被引量:1
  • 8Muta H, Ishii M, Egami K, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys inJapan[J].J Pediatr, 2004, 144(4): 496-499. 被引量:1
  • 9Muta H, Ishii M, Yashiro M, et al. Late intravenous immunoglobu-lin treatment in patients with Kawasaki disease [J]. Pediatrics,2012,129(2): 291-297. 被引量:1
  • 10Kuo HC, Yang KD, Chang WC, et al. Kawasaki disease: an updateon diagnosis and treatment [J]. PediatrNeonatol, 2012, 53(1): 4-11. 被引量:1

共引文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部